Clinical Trial Update: Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating chromium picolinate to prevent weight gain from serotonergic medications in psychiatric inpatients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Chromium Picolinate (chromium picolinate)

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: Weight Gain, Obesity | Phase 2 | Status: TERMINATED